0 results for 'US Food and Drug Administration'
The first federal trial over DePuy Orthopaedics Inc.'s metal-on-metal hip replacement device, which is the subject of about 10,000 lawsuits across the country, is scheduled to begin on September 9 in Cleveland.
OB-GYN Guidelines Inadmissible in Informed Consent Case
Health-care professional guidelines regarding whether a patient's surgery was appropriate are not admissible in the patient's informed consent action, the Superior Court has ruled in a memorandum opinion.Genetically Modified Wheat Litigation May Be Consolidated
The U.S. Judicial Panel on Multidistrict Litigation heard arguments on September 26 over whether to coordinate some 15 cases alleging that Monsanto, which conducted field testing on genetically modified wheat about a decade ago, contaminated crops intended for human consumption.Should Employers Consider Obesity A Protected Disability?
The Centers for Disease Control and Prevention report that more than one-third of adults in the United States are considered "obese."View more book results for the query "US Food and Drug Administration"
Sugar companies renew attack on corn refiners' advertising claims
Sugar producers fighting a marketing campaign that touts high fructose corn syrup as no different from table sugar were back in court on March 21, attempting to revive claims against five individual corn refiners.Sanctions Imposed for Non-Malevolent Destruction of Emails
"The law does not require a showing of malice to establish intentionality with respect to the spoliation of evidence," Southern District Judge Shira Scheindlin wrote. "In the context of an adverse inference analysis, there is no analytical distinction between destroying evidence in bad faith...and destroying it willfully."Research Institute's Legal Chief Resumes Dual Role With New Firm
David Welte essentially acted as the legal chief for the Stowers Institute for Medical Research since 2000, maintaining a concurrent role as a partner at Polsinelli Shalton Welte Suelthaus. This past January, Welte ended his 31-year relationship with the firm to become full-time general counsel for the biomedical institute. But a surprise announcement last month revealed that Welte would also be joining Bryan Cave's Kansas City, Mo., office, continuing the dual role he practiced at Polsinelli.Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now